Skip to main content
. Author manuscript; available in PMC: 2009 Jun 4.
Published in final edited form as: Technol Cancer Res Treat. 2009 Jun;8(3):187–200. doi: 10.1177/153303460900800303

Table III.

Dose-response parameters used in biological dosimetry evaluation.

D50 (Gy) γ s Endpoint
Spinal cord 57.00 6.70 1.00 Myelitis necrosis
Esophagus 68.00 2.8 3.40 Clinical stricture / perforation
Heart 70.70 0.96 1.00 Late excess cardiac mortality
Lung 15.90 1.00 0.17 Sever radiation pneumonitis, fibrosis
PTV 40.00 3.00 N/A Control